Quick Summary

Figwort (Scrophularia nodosa) is a plant with traditional uses and limited scientific research. Current evidence primarily involves molecular and genomic characterization of related species and alternative pharmacological research frameworks focusing on natural products, but direct clinical evidence on figwort itself is lacking.

What is it?

Figwort, scientifically known as Scrophularia nodosa, is a herbaceous plant belonging to the Scrophulariaceae family. It has been recognized in ethnobotanical literature for its traditional applications. Despite its historical use, it remains under-researched in clinical contexts.

Traditional Uses

Figwort has been documented in ethnobotanical works for various traditional purposes, although these uses have not been clinically validated. It has historically been utilized in folk remedies, typically for skin-related concerns and other general health uses, but detailed descriptions and verified efficacy are scarce.

Active Compounds

Specific active compounds in Scrophularia nodosa have not been well-characterized in clinical literature. Molecular and genomic studies have focused more broadly on the Scrophularia genus, but pinpointing phytochemical constituents directly responsible for any bioactivity in figwort requires further research.

Potential Benefits with Evidence Levels

  • Type 2 Diabetes: Insufficient clinical evidence.
    No direct clinical trials or systematic reviews on figwort for managing type 2 diabetes were identified. A 2026 systematic review discussed natural products with potential hypoglycemic activity using in vitro and in silico methods but did not specifically mention figwort. Other compounds such as citrus flavonoids have shown antidiabetic potential, though this is not attributed to figwort.
  • Wound Healing: No direct clinical evidence.
    While certain herbal extracts have been explored in preclinical models for wound healing, no clinical studies evaluating figwort specifically were found.
  • Phylogenetic and Genomic Studies: Preclinical/genomic characterization.
    Genomic and phylogenetic analyses of the Scrophularia incisa complex, which includes related species, have enhanced understanding of species delimitation and plastome evolution in this genus.
  • Traditional / Ethnobotanical Use: Traditional use without clinical validation.
    Figwort is described in ethnobotanical literature but lacks robust clinical trials to confirm therapeutic effects.

Side Effects

There is currently no documented clinical evidence or reports describing adverse effects related to figwort use in humans based on available data.

Drug Interactions

No evidence regarding potential drug interactions with figwort has been identified in clinical or preclinical literature to date.

Who Should Avoid It

No specific contraindications for figwort use have been established due to the lack of clinical studies. However, caution is advised during pregnancy and breastfeeding as there are no safety data available for these populations.

Evidence Limitations

Clinical research addressing the efficacy, safety, indications, adverse effects, drug interactions, or contraindications of Scrophularia nodosa is lacking. Most information originates from genomic studies, traditional knowledge, or preclinical research frameworks that do not directly investigate figwort’s therapeutic use. No randomized controlled trials or human clinical trials have been identified. Therefore, claims of therapeutic benefit should not be inferred from indirect or unrelated studies.

References

  • Espinoza-Hernández FA, Martínez-Medina S, Mata-Torres G, Cabello-Hernández CA, Andrade-Cetto A. Alternative methods for pharmacological research on the action mechanisms of natural products used in the treatment of type 2 diabetes: a systematic review. Europe PMC. 2026. https://pubmed.ncbi.nlm.nih.gov/41743124/
  • Wang R, Gao J, Feng J, Yang Z, Qi Z, Li P, Fu C. Comparative and Phylogenetic Analyses of Complete Chloroplast Genomes of Scrophularia incisa Complex (Scrophulariaceae). Europe PMC. 2022. https://pubmed.ncbi.nlm.nih.gov/36292576/
  • Scrophularia nodosa L.Scrophulariacae. In: Ethnobotany of Mountain Regions. Springer International Publishing; 2024. doi:10.1007/978-3-030-98744-2_265-1
  • Scrophularia nodosa, figwort. In: Medical Herbs. Elsevier; 2011. doi:10.1016/b978-0-443-10344-5.00033-1

Last Reviewed

June 2024

Disclaimer: This page is for informational purposes only and does not constitute medical advice. The safety and efficacy of figwort (Scrophularia nodosa) have not been established through clinical trials. Consult a qualified healthcare professional before using any herbal products, especially if you are pregnant, breastfeeding, have existing health conditions, or are taking other medications.